Sale!
,

PT141 10mg (Vial)

Original price was: R630,00.Current price is: R530,00.

Studied for its role in:

  • Libido activation
  • Sexual response signaling
  • Central neurological pathways.

PT-141 (Bremelanotide)

Precision Synthesized | Research Grade Compound


Next-generation melanocortin-pathway compound at the forefront of libido and sexual-response research.

Precision synthesized. Research-grade quality.


OVERVIEW

PT-141 (Bremelanotide) is a synthetic analogue of alpha-melanocyte-stimulating hormone (α-MSH), developed to interact with melanocortin receptors within the central nervous system.

Unlike traditional approaches that focus on blood flow, PT-141 is studied for its direct influence on neurological pathways linked to libido and sexual response. It primarily targets receptor systems in the brain associated with internal desire signaling, motivation, and arousal-related activation.

This makes it a key compound in research models exploring how libido and sexual response can be influenced through central mechanisms rather than peripheral systems.


RESEARCH FOCUS AREAS

Libido & Sexual Response Pathways
Studied in relation to internal signaling mechanisms that influence desire, arousal, and sexual response.

Neurological Activation & Signaling
Observed in research exploring how central nervous system pathways regulate motivation and behavioral response.

Melanocortin Receptor Activity
Investigated for its interaction with MC3R and MC4R receptors associated with desire-related signaling.

Response Timing & Activation Patterns
Preliminary studies indicate involvement in pathways linked to rapid-onset neurological and physiological responses.


RESEARCH APPLICATIONS

  • Libido and sexual response pathway studies
  • Neurological activation and signaling research
  • Melanocortin receptor system analysis
  • Behavioral response modelling
  • Central pathway activation studies

SCIENTIFIC REFERENCES

Long-Term Safety and Efficacy of Bremelanotide (2019):
https://pubmed.ncbi.nlm.nih.gov/31599847/

Bremelanotide for the Treatment of HSDD: Phase 3 Trials (2019):
https://pmc.ncbi.nlm.nih.gov/articles/PMC6819021/

Melanocortin Receptors and Penile Erection Research:
https://pmc.ncbi.nlm.nih.gov/articles/PMC2694735/

PT-141: A Melanocortin Agonist for Sexual Dysfunction:
https://pubmed.ncbi.nlm.nih.gov/12851303/


IMPORTANT NOTICE

This compound is supplied strictly for laboratory research purposes only.

Demure Peptides™ operates as a private sourcing and payment facilitation platform, connecting clients to independent third-party supply channels. All fulfilment, handling, and packaging are conducted externally.

Product imagery is for illustrative purposes. Supplied items may differ in appearance, size, and third-party laboratory branding.

This product is not intended for human consumption.

This product has not been evaluated by the South African Health Products Regulatory Authority and is not intended to diagnose, treat, cure, or prevent any disease.


ADDITIONAL INFORMATION

  • Peptide Name: PT-141 (Bremelanotide)
  • Category: Libido / Neurological Research Peptide
  • Format: Vial
  • CAS Number: 189691-06-3 (Free Base) / 1607799-13-2 (Acetate)

Reviews

There are no reviews yet.

Be the first to review “PT141 10mg (Vial)”

Your email address will not be published. Required fields are marked *

Scroll to Top